ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
Mapping the intricate relationship between mental disorders and inflammation: research trends and pharmacological implications.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The etiology of mental disorders continues to present a profound conundrum, with many theoretical frameworks seeking to clarify the underlying psychopathological mechanisms. Among these, the inflammatory hypothesis suggests that immune-mediated inflammation is integral to the emergence and progression of mental disorders, thus proposing a plausible mechanism. Nonetheless, bibliometric analyses that systematically aggregate and scrutinize the existing literature within this field are lacking. To address this gap in knowledge, the present study performed comprehensive bibliometric analyses and used a visualization methodology to investigate this subject using several approaches, such as analyses of publication trends, keywords, authorship patterns, and geographical distribution, collectively encompassing a dataset of 24,226 publications. Our results revealed proliferation and persistent dynamism in this area of research over the past 26 years, with the primary research focal point being the interaction between inflammation and affective disorders, particularly depression. Furthermore, emerging areas of interest include gut microbiota, neuroimaging, and metabolism. We further discussed the pharmacological potential of targeting inflammation in psychiatric disorders regarding novel drug discovery, positing that the heterogeneous outcomes of prior trials may be attributed to insufficient stratification of inflammatory phenotypes, underscoring the need for future psychopharmacological studies to precisely align intervention strategies with patient-specific inflammatory profiles. Figuring out the intricate nexus between mental disorders and inflammation is essential to improve our understanding of psychopathology and identify novel therapeutic targets.
Indexed as
Identifiers
41609857What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.